Treatment of Pulmonary Disease Caused by Mycobacterium Avium Complex

Internal Medicine - Japan
doi 10.2169/internalmedicine.42.627
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Secondary Mycobacterium Avium Complex (MAC) Pulmonary Disease

2019English

Recurrence of Pulmonary Mycobacterium Avium Complex Disease Due to Endogenous Reactivation

JMM Case Reports
Microbiology
2014English

Clinical Factors on Cavitary and Nodular Bronchiectatic Types in Pulmonary Mycobacterium Avium Complex Disease

Internal Medicine
Internal MedicineMedicine
2008English

Comparison of Clinical Characteristics of Patients With Mycobacterium Avium Complex Disease by Gender

Epidemiology and Infection
EpidemiologyInfectious Diseases
2019English

Therapeutic Effects of Various Initial Combinations of Chemotherapy Including Clarithromycin Against Mycobacterium Avium Complex Pulmonary Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2009English

Clinical Characteristics and Treatment Outcomes of Patients With Macrolide-Resistant Mycobacterium Avium Complex Pulmonary Disease: A Systematic Review and Meta-Analysis

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Treatment of Pulmonary Disease Caused by Opportunist Mycobacteria.

Thorax
PulmonaryRespiratory Medicine
1989English

Characteristic Chest CT Findings for Progressive Cavities in Mycobacterium Avium Complex Pulmonary Disease: A Retrospective Cohort Study

Respiratory Research
PulmonaryRespiratory Medicine
2020English

Liposome-Encapsulated Gentamicin Treatment of Mycobacterium Avium-Mycobacterium Intracellulare Complex Bacteremia in AIDS Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy